Adil Sabr Al-Ogaili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adil Sabr Al-Ogaili has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Billy M. Hargis
Department of Poultry Science, University of Arkansas System Division of Agriculture
3 shared publications- Samer Sadeq Hameed
Department of Pathology and Diseases of Poultry, College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq
3 shared publications - Young Min Kwon
Department of Poultry Science, University of Arkansas System, Division of Agriculture, 1260W. Maple, Fayetteville, AR 72701, USA
3 shared publications Christine N. Vuong
Department of Poultry Science, University of Arkansas System Division of Agriculture
2 shared publicationsYoung Min Kwon
Department of Cell and Molecular Biology, University of Arkansas, Fayetteville, AR 72701, Center of Excellence for Poultry Science, University of Arkansas, Fayetteville, AR 7270
2 shared publicationsAbigeal I. Omolewu
Department of Poultry Science, University of Arkansas System Division of Agriculture
1 shared publication
Latest Publications
- Open Access
- 24 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3808
In Silico Study of Anti-CD40 DNA Aptamers as Vaccine Adjuvants for Chickens
We performed a protein-docking study for eight DNA aptamers (SEQ1–SEQ8) against chicken Cluster of Differentiation 40 (chCD40), which were experimentally identified via SELEX in our previous study. In silico and molecular docking analyses were performed to predict and obtain the secondary and tertiary structures of the aptamers. Aptamers SEQ3 and SEQ4, which showed the best inhibitory effects, were selected and utilized to produce a DNA-based vaccine adjuvant using rolling circle amplification (RCA). These aptamers had been previously characterized via mass spectroscopy to determine their molecular weight and regions that could potentially interact with chCD40. In the present study, these results were corroborated and expanded. A series of free software methods, including Mfold v.1.0, 3dADN v.2.0, ClusPro v.2.0, Hdock v.1.0, and PLIP v.1.0, were used to determine the aptamers’ secondary and tertiary structures and docking interactions, as well as the specific residues involved in the interactions and their distances. The structures were used to explain and thus understand their effect on the binding, selectivity, and stability of the aptamers. The main objective of the study was to determine whether these aptamers could be used as vaccine adjuvants against viral and bacterial pathogens, specifically chicken avian influenza. The docking results were in good agreement with the experimental and biological results. The procedure employed in this study could be an easy and effective tool for exploring the potential of the new technology of systematic evolution of ligands by exponential enrichment (SELEX) in the preparation of aptamers to control viral and bacterial infections as well as diseases, such as cancer and Alzheimer’s.
- 24 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (9) , 3808
Open AccessIn Silico Study of Anti-CD40 DNA Aptamers as Vaccine Adjuvants for Chickens
We performed a protein-docking study for eight DNA aptamers (SEQ1–SEQ8) against chicken Cluster of Differentiation 40 (chCD40), which were experimentally identified via SELEX in our previous study. In silico and molecular docking analyses were performed to predict and obtain the secondary and tertiary structures of the aptamers. Aptamers SEQ3 and SEQ4, which showed the best inhibitory effects, were selected and utilized to produce a DNA-based vaccine adjuvant using rolling circle amplification (RCA). These aptamers had been previously characterized via mass spectroscopy to determine their molecular weight and regions that could potentially interact with chCD40. In the present study, these results were corroborated and expanded. A series of free software methods, including Mfold v.1.0, 3dADN v.2.0, ClusPro v.2.0, Hdock v.1.0, and PLIP v.1.0, were used to determine the aptamers’ secondary and tertiary structures and docking interactions, as well as the specific residues involved in the interactions and their distances. The structures were used to explain and thus understand their effect on the binding, selectivity, and stability of the aptamers. The main objective of the study was to determine whether these aptamers could be used as vaccine adjuvants against viral and bacterial pathogens, specifically chicken avian influenza. The docking results were in good agreement with the experimental and biological results. The procedure employed in this study could be an easy and effective tool for exploring the potential of the new technology of systematic evolution of ligands by exponential enrichment (SELEX) in the preparation of aptamers to control viral and bacterial infections as well as diseases, such as cancer and Alzheimer’s.
- Open Access
- 30 March 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1735450
In vitro evaluation of CD40-targeting aptamer-based DNA vaccine adjuvants using HD11 cell culture
Salmonella is a major foodborne pathogen that colonizes the gastrointestinal tract of poultry, compromising bird health and productivity while posing significant public health threats. Consumption of contaminated poultry products is the leading cause of Salmonella -related illnesses in humans. Although numerous vaccination strategies exist, weak immune responses often limit the efficacy. One promising approach to address this limitation is targeting the cluster of Differentiation 40 (CD40), a costimulatory receptor expressed on antigen-presenting cells that plays a crucial role in initiating and regulating immune response. In this study, we developed two rolling circle amplification (RCA) vaccine complexes (RCA_v3 and RCA_v5) against Salmonella , each comprising a CD40-targeting component to enhance immune activation (Aptamer RCA II) and a Salmonella -binding component for antigen delivery (Anti- Salmonella RCA). We evaluated the two RCA vaccine complex designs for their ability to activate macrophages in the HD11 chicken cell line by quantifying nitric oxide production via the Griess assay. The results showed that the two RCA vaccine designs (RCA_v3 and RCA_v5) combined with formalin-killed Salmonella Enteritidis (SE) significantly (58.00 μM and 52.08 μM, respectively) enhanced macrophage activation ( p < 0.05) compared to SE alone (33.37 μM). Also, the activation levels of RCA_v3 vaccine complex were significantly higher with SE as compared with the respective counterparts without SE, RCA_v3 alone, and Aptamer RCA II (35.13 μM and 39.02 μM, respectively) ( p < 0.05). These findings offer valuable insights into developing effective vaccination strategies to control Salmonella colonization in poultry, presenting a promising approach to improving food safety and reducing public health risks associated with Salmonella infections in chickens.
- 30 March 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1735450
Open AccessIn vitro evaluation of CD40-targeting aptamer-based DNA vaccine adjuvants using HD11 cell culture
Salmonella is a major foodborne pathogen that colonizes the gastrointestinal tract of poultry, compromising bird health and productivity while posing significant public health threats. Consumption of contaminated poultry products is the leading cause of Salmonella -related illnesses in humans. Although numerous vaccination strategies exist, weak immune responses often limit the efficacy. One promising approach to address this limitation is targeting the cluster of Differentiation 40 (CD40), a costimulatory receptor expressed on antigen-presenting cells that plays a crucial role in initiating and regulating immune response. In this study, we developed two rolling circle amplification (RCA) vaccine complexes (RCA_v3 and RCA_v5) against Salmonella , each comprising a CD40-targeting component to enhance immune activation (Aptamer RCA II) and a Salmonella -binding component for antigen delivery (Anti- Salmonella RCA). We evaluated the two RCA vaccine complex designs for their ability to activate macrophages in the HD11 chicken cell line by quantifying nitric oxide production via the Griess assay. The results showed that the two RCA vaccine designs (RCA_v3 and RCA_v5) combined with formalin-killed Salmonella Enteritidis (SE) significantly (58.00 μM and 52.08 μM, respectively) enhanced macrophage activation ( p < 0.05) compared to SE alone (33.37 μM). Also, the activation levels of RCA_v3 vaccine complex were significantly higher with SE as compared with the respective counterparts without SE, RCA_v3 alone, and Aptamer RCA II (35.13 μM and 39.02 μM, respectively) ( p < 0.05). These findings offer valuable insights into developing effective vaccination strategies to control Salmonella colonization in poultry, presenting a promising approach to improving food safety and reducing public health risks associated with Salmonella infections in chickens.
- Open Access
- 10 November 2024
- Published by Middle Technical University in Iraqi Journal of Medical and Health Sciences
- Vol. 1 (1) , 14-21
Efficient Correction of DNA Hetero–Duplexes Formed During SELEX Procedure
Background: Aptamers, oligos-based (ssDNA or RNA) and peptide-based, are now emerging as the first-choice biomolecules in various applications in medicine and biology. DNA aptamers selection process includes repeatable steps of DNA amplification and digestion. The amplification process of the enriched DNA aptamers includes using PCR. Objective of study: In this article, we sought to describe an efficient and robust method that corrects or permanently removes the PCR by–products during the cycles of DNA aptamers selection. Materials and Methods: Our method is simple, efficient, and requires no enzymatic treatment. In this method, we applied repetitive cycles of thermal treatment to the enriched aptamers final products during the enrichment cycles. The procedure starts with loading the PCR-induced DNA on 1% agarose gel to evaluate the presence of ladder-like DNA or smearing band-like DNA. Next, we cut and purified these by–products and applied thermal treatment. The thermal treatment was by heating the DNA to 65ºC for 10 minutes and then cool them down to 20ºC for 1 minute. Results: PCR artifacts evaluation has been revealed two types of unwanted DNA sequences; the ladder-like and the smearing bands. The next–Generation illume sequencing specified the presence of long and short sequences. Upon the thermal treatment of the PCR products, the next–generation illume sequencing method results showed that the longer sequences and the shorter sequences of the DNA have been reduced considerably and effectively in the DNA pool over the cycles of the systemic evolution of ligands by exponential enrichment (SELEX) procedure. Furthermore, we could reduce the formation of the hetero–duplexes in the next cycles of (SELEX) procedure. Conclusion: This method suggests practical and routine application to prevent or reduce DNA aptamer by–products during the selection process. This treatment could reduce the mis-shaped or irrelevant non-functional aptamers in SELEX procedure
- 10 November 2024
- Published by Middle Technical University in Iraqi Journal of Medical and Health Sciences
- Vol. 1 (1) , 14-21
Open AccessEfficient Correction of DNA Hetero–Duplexes Formed During SELEX Procedure
Background: Aptamers, oligos-based (ssDNA or RNA) and peptide-based, are now emerging as the first-choice biomolecules in various applications in medicine and biology. DNA aptamers selection process includes repeatable steps of DNA amplification and digestion. The amplification process of the enriched DNA aptamers includes using PCR. Objective of study: In this article, we sought to describe an efficient and robust method that corrects or permanently removes the PCR by–products during the cycles of DNA aptamers selection. Materials and Methods: Our method is simple, efficient, and requires no enzymatic treatment. In this method, we applied repetitive cycles of thermal treatment to the enriched aptamers final products during the enrichment cycles. The procedure starts with loading the PCR-induced DNA on 1% agarose gel to evaluate the presence of ladder-like DNA or smearing band-like DNA. Next, we cut and purified these by–products and applied thermal treatment. The thermal treatment was by heating the DNA to 65ºC for 10 minutes and then cool them down to 20ºC for 1 minute. Results: PCR artifacts evaluation has been revealed two types of unwanted DNA sequences; the ladder-like and the smearing bands. The next–Generation illume sequencing specified the presence of long and short sequences. Upon the thermal treatment of the PCR products, the next–generation illume sequencing method results showed that the longer sequences and the shorter sequences of the DNA have been reduced considerably and effectively in the DNA pool over the cycles of the systemic evolution of ligands by exponential enrichment (SELEX) procedure. Furthermore, we could reduce the formation of the hetero–duplexes in the next cycles of (SELEX) procedure. Conclusion: This method suggests practical and routine application to prevent or reduce DNA aptamer by–products during the selection process. This treatment could reduce the mis-shaped or irrelevant non-functional aptamers in SELEX procedure
- Open Access
- 11 May 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (5) , 1171-1176
Single-stranded DNA aptamer-based rolling circle amplification as anti-chicken Salmonella bacteriostatic
Background and Aim: Salmonella is a major foodborne pathogen in the poultry industry, wherein the control measures may include sanitation and antibacterial and vaccines. However, there have been severe global restrictions on using anti-Salmonella antibacterial agents in livestock. This situation, along with rapidly increasing drug-resistant bacterial species, has led to the exploration of unconventional methods to control Salmonella infection in poultry. In recent years, selection techniques of promising DNA aptamers have begun to permeate several medical branches, resulting in the development of numerous anti-Salmonella DNA aptamers, most of which are used as sensing molecules for diagnostic purposes. These DNA aptamers have been demonstrated to interfere with bacterial growth, multiplication, and viability. Aptamers formed in rolling circle amplification products (RCA-p) could improve the potential action of aptamer interference with bacteria. This study aimed to test the use of single-stranded DNA aptamers in the form of RCA-p as a bacteriostatic to Salmonella in vitro. Materials and Methods: Salmonella Typhimurium and Salmonella Enteritidis isolates were subjected to the action of anti-ST and anti-SE DNA aptamers in the form of RCA-p. Each isolate was grown on MacConkey and Luria-Bertani agar media separately in different concentrations in the presence or absence of the cognate RCA-p. Results: The anti-Salmonella species DNA aptamer-based RCA-p were capable of reducing bacterial growth to significant levels in vitro. Conclusion: We describe a potential solution for the rapidly developing drug resistance of several bacterial species. Our findings suggested that the use of non-toxic, non-immunogenic, and low-cost DNA aptamers targeting Salmonella in the form of RCA-p could inhibit the bacterial growth rate. Unlike polymerase chain reaction, RCA yields tandem repeats of single-stranded DNA at isothermal conditions, which would increase the probability of receptor-ligand clustering and increase affinity. Furthermore, as our RCA template was bivalent with two DNA aptamer sequences, we could target multiple sites or antigens on a bacterial cell.
- 11 May 2022
- Published by Veterinary World in Veterinary World
- Vol. 15 (5) , 1171-1176
Open AccessSingle-stranded DNA aptamer-based rolling circle amplification as anti-chicken Salmonella bacteriostatic
Background and Aim: Salmonella is a major foodborne pathogen in the poultry industry, wherein the control measures may include sanitation and antibacterial and vaccines. However, there have been severe global restrictions on using anti-Salmonella antibacterial agents in livestock. This situation, along with rapidly increasing drug-resistant bacterial species, has led to the exploration of unconventional methods to control Salmonella infection in poultry. In recent years, selection techniques of promising DNA aptamers have begun to permeate several medical branches, resulting in the development of numerous anti-Salmonella DNA aptamers, most of which are used as sensing molecules for diagnostic purposes. These DNA aptamers have been demonstrated to interfere with bacterial growth, multiplication, and viability. Aptamers formed in rolling circle amplification products (RCA-p) could improve the potential action of aptamer interference with bacteria. This study aimed to test the use of single-stranded DNA aptamers in the form of RCA-p as a bacteriostatic to Salmonella in vitro. Materials and Methods: Salmonella Typhimurium and Salmonella Enteritidis isolates were subjected to the action of anti-ST and anti-SE DNA aptamers in the form of RCA-p. Each isolate was grown on MacConkey and Luria-Bertani agar media separately in different concentrations in the presence or absence of the cognate RCA-p. Results: The anti-Salmonella species DNA aptamer-based RCA-p were capable of reducing bacterial growth to significant levels in vitro. Conclusion: We describe a potential solution for the rapidly developing drug resistance of several bacterial species. Our findings suggested that the use of non-toxic, non-immunogenic, and low-cost DNA aptamers targeting Salmonella in the form of RCA-p could inhibit the bacterial growth rate. Unlike polymerase chain reaction, RCA yields tandem repeats of single-stranded DNA at isothermal conditions, which would increase the probability of receptor-ligand clustering and increase affinity. Furthermore, as our RCA template was bivalent with two DNA aptamer sequences, we could target multiple sites or antigens on a bacterial cell.
- Open Access
- 1 January 2022
- Published by ScopeMed in Open Veterinary Journal
- Vol. 12 (2) , 197-203
LPS-induced NLRP3 gene-expression in chicken
NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) is a cytosolic sensor that detects many microbial pathogen-associated molecular patterns and damage-associated molecular patterns. It works as a pro-inflammatory cytokine that is encoded in the NLRP3 gene. This protein is profoundly expressed in macrophage and other innate immune system cells, and participates in the assembly of NLRP3 inflammasome. NLRP3 inflammasome activates caspase-1, which in turn renders the inactive precursors of the pro-inflammatory cytokines, the interleukin-1β (IL-1β) and the IL-18, into active forms. This cytokine may trigger many inflammatory responses and cell signaling pathways as well. Little is known about this cytokine in chickens, especially its role in vaccines or induced immune responses. In this article, we sought to determine the presence of this gene mRNA in selected organs of male and female commercial, brown leghorn egg-type chickens. In addition, we sought to determine this gene’s potential expression in these organs upon stimulation. Using real-time polymerase chain reaction, first we tested the presence of the NLRP3 gene in the chickens. Second, the levels and the time course of NLRP3 gene expression have been tested after stimulation with bacterial lipopolysaccharide (LPS) for 12, 24, and 48 hours postinoculation (pi). One-hundred twenty, day-old males and females egg-type brown leghorn chickens were used for the study. Our results showed that the gene mRNA is actually present in chickens solely. Also, there were no significant differences in the density of the expression and the distribution of the expression of the NLRP3 between male and female chickens and among different organs. Upon stimulation with LPS administration, however, there were marked elevations in the gene expression rates in small intestine, large intestine, gizzard, liver, lung, spleen, and Peyer’s patches 12 hours pi. This elevation continued to elevate 24 hours pi. However, the significance of the expression was only recorded in the small intestine, large intestine, and with less significance, in Peyer’s patches and spleen. This elevation in expression subsided and almost returned to normal within these organs 48 hours pi. The results suggest that there were no significant differences in the NLRP3 gene expression between male and female. Upon stimulation, the course of the gene expression showed a time-dependent response. First, the dominance in the NLRP3 gene mRNA expression was in the small intestine and gizzard. Similarly, but less profoundly, the large intestine, Peyer’s patches, and spleen expressed NLRP3 mRNA 12 and 24 hours pi with LPS. Secondary immune organs, lungs, small intestine, and large intestine expressed the NLRP3 mRNA significantly 24 hours pi. All the levels had diminished and almost returned to normal 48 hours pi.
- 1 January 2022
- Published by ScopeMed in Open Veterinary Journal
- Vol. 12 (2) , 197-203
Open AccessLPS-induced NLRP3 gene-expression in chicken
NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) is a cytosolic sensor that detects many microbial pathogen-associated molecular patterns and damage-associated molecular patterns. It works as a pro-inflammatory cytokine that is encoded in the NLRP3 gene. This protein is profoundly expressed in macrophage and other innate immune system cells, and participates in the assembly of NLRP3 inflammasome. NLRP3 inflammasome activates caspase-1, which in turn renders the inactive precursors of the pro-inflammatory cytokines, the interleukin-1β (IL-1β) and the IL-18, into active forms. This cytokine may trigger many inflammatory responses and cell signaling pathways as well. Little is known about this cytokine in chickens, especially its role in vaccines or induced immune responses. In this article, we sought to determine the presence of this gene mRNA in selected organs of male and female commercial, brown leghorn egg-type chickens. In addition, we sought to determine this gene’s potential expression in these organs upon stimulation. Using real-time polymerase chain reaction, first we tested the presence of the NLRP3 gene in the chickens. Second, the levels and the time course of NLRP3 gene expression have been tested after stimulation with bacterial lipopolysaccharide (LPS) for 12, 24, and 48 hours postinoculation (pi). One-hundred twenty, day-old males and females egg-type brown leghorn chickens were used for the study. Our results showed that the gene mRNA is actually present in chickens solely. Also, there were no significant differences in the density of the expression and the distribution of the expression of the NLRP3 between male and female chickens and among different organs. Upon stimulation with LPS administration, however, there were marked elevations in the gene expression rates in small intestine, large intestine, gizzard, liver, lung, spleen, and Peyer’s patches 12 hours pi. This elevation continued to elevate 24 hours pi. However, the significance of the expression was only recorded in the small intestine, large intestine, and with less significance, in Peyer’s patches and spleen. This elevation in expression subsided and almost returned to normal within these organs 48 hours pi. The results suggest that there were no significant differences in the NLRP3 gene expression between male and female. Upon stimulation, the course of the gene expression showed a time-dependent response. First, the dominance in the NLRP3 gene mRNA expression was in the small intestine and gizzard. Similarly, but less profoundly, the large intestine, Peyer’s patches, and spleen expressed NLRP3 mRNA 12 and 24 hours pi with LPS. Secondary immune organs, lungs, small intestine, and large intestine expressed the NLRP3 mRNA significantly 24 hours pi. All the levels had diminished and almost returned to normal 48 hours pi.
- Open Access
- 19 July 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (7) , 1846-1852
Development of lymphocyte subpopulations in local breed chickens
Background and Aim: Local breeds of chicken are known to have relatively higher disease resistance to many endemic diseases and diseases that are highly virulent in commercial chickens. This study aimed to address the lymphocyte subpopulations in three constitutive immune system organs (thymus, bursa of Fabricius, and spleen) in 30, 8-week-old, male local breed chickens. Materials and Methods: The T (CD3+) and B lymphocytes (Bu-1+) were identified through one-color, direct immunofluorescent staining of the thymus, bursa, and spleen lymphocytes. Likewise, two-color, direct immunofluorescent staining was performed to identify the CD4- and/or CD8-defined T lymphocytes. The proportions of T and B lymphocytes and CD4- and/or CD8 defined chicken lymphocyte subsets in lymphoid suspensions prepared from the thymus, bursa, and spleen were determined by flow cytometry. Results: CD3+ cells, particularly those positive for CD4+CD8–, were dominant in the thymus, whereas cells expressing the Bu-1 marker were predominant in the bursa of Fabricius. The proportion of T and B cells was almost equal in the spleen, with more cells expressing the CD4–CD8+ marker in the red pulp. Conclusion: These findings indicate that local breeds of chicken could serve as a reliable model for studying the immune system of commercial light chicken breeds, due to the similarity in the presence and the distribution of the immune cells.
- 19 July 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (7) , 1846-1852
Open AccessDevelopment of lymphocyte subpopulations in local breed chickens
Background and Aim: Local breeds of chicken are known to have relatively higher disease resistance to many endemic diseases and diseases that are highly virulent in commercial chickens. This study aimed to address the lymphocyte subpopulations in three constitutive immune system organs (thymus, bursa of Fabricius, and spleen) in 30, 8-week-old, male local breed chickens. Materials and Methods: The T (CD3+) and B lymphocytes (Bu-1+) were identified through one-color, direct immunofluorescent staining of the thymus, bursa, and spleen lymphocytes. Likewise, two-color, direct immunofluorescent staining was performed to identify the CD4- and/or CD8-defined T lymphocytes. The proportions of T and B lymphocytes and CD4- and/or CD8 defined chicken lymphocyte subsets in lymphoid suspensions prepared from the thymus, bursa, and spleen were determined by flow cytometry. Results: CD3+ cells, particularly those positive for CD4+CD8–, were dominant in the thymus, whereas cells expressing the Bu-1 marker were predominant in the bursa of Fabricius. The proportion of T and B cells was almost equal in the spleen, with more cells expressing the CD4–CD8+ marker in the red pulp. Conclusion: These findings indicate that local breeds of chicken could serve as a reliable model for studying the immune system of commercial light chicken breeds, due to the similarity in the presence and the distribution of the immune cells.
- Open Access
- 17 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant
Several agonists to CD40 have shown to induce acquired immune responses. Here, we developed and evaluated the rolling circle amplification (RCA) products that are based on anti-CD40 DNA aptamers as a novel vaccine adjuvant. First, we developed DNA aptamers with specific binding affinity to chicken CD40 extra domain (chCD40ED). Next, we prepared the RCA products that consist of these aptamers to increase the spanning space and overall binding affinity to chCD40ED. Using 8 DNA aptamer candidates, 4 aptamer-based RCA products (aptamer RCAs) were generated, each consisting of two distinct aptamers. We demonstrated that all 4 aptamer RCAs significantly induced the signal transduction in chicken HD11 macrophage cell line (p < 0.05). Finally, we conjugated one of the aptamer RCAs (Aptamer RCA II) to M2e epitope peptide of influenza virus as a model hapten, and the immune complex was injected to chickens. Aptamer RCA II stimulated anti-M2e IgG antibody production to the level significantly higher as compared to the control (M2e epitope alone; p < 0.05). The results of our work suggest that aptamer RCA is a novel platform to boost the efficacy of vaccines, which might find broad applications to other antigens beyond M2e epitope evaluated in this study using chicken infection model.
- 17 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Open AccessDNA aptamer-based rolling circle amplification product as a novel immunological adjuvant
Several agonists to CD40 have shown to induce acquired immune responses. Here, we developed and evaluated the rolling circle amplification (RCA) products that are based on anti-CD40 DNA aptamers as a novel vaccine adjuvant. First, we developed DNA aptamers with specific binding affinity to chicken CD40 extra domain (chCD40ED). Next, we prepared the RCA products that consist of these aptamers to increase the spanning space and overall binding affinity to chCD40ED. Using 8 DNA aptamer candidates, 4 aptamer-based RCA products (aptamer RCAs) were generated, each consisting of two distinct aptamers. We demonstrated that all 4 aptamer RCAs significantly induced the signal transduction in chicken HD11 macrophage cell line (p < 0.05). Finally, we conjugated one of the aptamer RCAs (Aptamer RCA II) to M2e epitope peptide of influenza virus as a model hapten, and the immune complex was injected to chickens. Aptamer RCA II stimulated anti-M2e IgG antibody production to the level significantly higher as compared to the control (M2e epitope alone; p < 0.05). The results of our work suggest that aptamer RCA is a novel platform to boost the efficacy of vaccines, which might find broad applications to other antigens beyond M2e epitope evaluated in this study using chicken infection model.
- Open Access
- 23 January 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (4)
Draft Genome Sequence of Clostridium perfringens Strain TAMU, Which Causes Necrotic Enteritis in Broiler Chickens
Clostridium perfringens causes severe gastrointestinal diseases, which include necrotic enteritis (NE) in chickens, a deadly disease worldwide. We report here the draft genome sequence of Clostridium perfringens strain TAMU, which was used in developing an NE chicken challenge model. This C. perfringens TAMU genome sequence will aid in advancing potential intervention strategies to reduce NE pathogenesis.
- 23 January 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (4)
Open AccessDraft Genome Sequence of Clostridium perfringens Strain TAMU, Which Causes Necrotic Enteritis in Broiler Chickens
Clostridium perfringens causes severe gastrointestinal diseases, which include necrotic enteritis (NE) in chickens, a deadly disease worldwide. We report here the draft genome sequence of Clostridium perfringens strain TAMU, which was used in developing an NE chicken challenge model. This C. perfringens TAMU genome sequence will aid in advancing potential intervention strategies to reduce NE pathogenesis.
- Open Access
- 28 June 2011
- Published by Baghdad University College of Veterinary Medicine in The Iraqi Journal of Veterinary Medicine
- Vol. 35 (1) , 37-41
Detection of the Immune Response in Broiler Breeders, and Their progeny to Newcastle Disease Vaccine
This trail was suggested to evaluate the amount of inherited haemagglutination inhibition (HI) antibodies for Newcastle Disease (ND) from hens to their own progeny via yolk, blood samples were collected from broiler breeders at 51st week of age aiming the collection their sera, these hens were previously vaccinated with ND-killed vaccine at the age 5 and 120 days respectively via subcutaneous route; and ND-alive vaccine at 1and 18 days then monthly intervals by aerosol, random samples of eggs were collected from panels or hatchery machines either after 24h., to detect amount and location of HI antibodies through them, day old chicks were submitted to the same protocol of blood collection as well as mothers. The results showed that the combination manner of vaccines is an ideal way of HI antibodies peak elevation, these antibodies can pass vertically from dam to progeny through yolk, and the yolk material can be used to detect the HI antibody titer by routine process.
- 28 June 2011
- Published by Baghdad University College of Veterinary Medicine in The Iraqi Journal of Veterinary Medicine
- Vol. 35 (1) , 37-41
Open AccessDetection of the Immune Response in Broiler Breeders, and Their progeny to Newcastle Disease Vaccine
This trail was suggested to evaluate the amount of inherited haemagglutination inhibition (HI) antibodies for Newcastle Disease (ND) from hens to their own progeny via yolk, blood samples were collected from broiler breeders at 51st week of age aiming the collection their sera, these hens were previously vaccinated with ND-killed vaccine at the age 5 and 120 days respectively via subcutaneous route; and ND-alive vaccine at 1and 18 days then monthly intervals by aerosol, random samples of eggs were collected from panels or hatchery machines either after 24h., to detect amount and location of HI antibodies through them, day old chicks were submitted to the same protocol of blood collection as well as mothers. The results showed that the combination manner of vaccines is an ideal way of HI antibodies peak elevation, these antibodies can pass vertically from dam to progeny through yolk, and the yolk material can be used to detect the HI antibody titer by routine process.